{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:39:34Z","timestamp":1784702374460,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ClinicalTrials.gov","award":["NCT00892047"],"award-info":[{"award-number":["NCT00892047"]}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH083648"],"award-info":[{"award-number":["R01 MH083648"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","award":["R01 MH083643"],"award-info":[{"award-number":["R01 MH083643"]}],"id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007408","name":"University of Pittsburgh Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000448"],"award-info":[{"award-number":["UL1 TR000448"]}],"id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Mental Health","award":["R25 MH112473"],"award-info":[{"award-number":["R25 MH112473"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Medicare and Medicaid Services (CMS)"},{"name":"Pittsburgh Sleep Quality Index","award":["PRO10050447"],"award-info":[{"award-number":["PRO10050447"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH"},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center for Brain Research in Mood Disorders (CBRiMD)"},{"name":"Center for Diabetes Translational Research (CDTR)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jpsychires.2019.04.017","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T08:39:29Z","timestamp":1556008769000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazole"],"prefix":"10.1016","volume":"114","author":[{"given":"H.","family":"Oughli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Lenze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Yingling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"C.F.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.","family":"Newcomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E.","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jagp.2017.05.012","article-title":"Pharmacogenetic decision support tools: a new paradigm for late-life depression?","volume":"26","author":"Abbott","year":"2018","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2019.04.017_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal","volume":"22","author":"Alvarez-Jim\u00e9nez","year":"2008","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.jpsychires.2019.04.017_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00702-017-1806-8","article-title":"The role of depression pharmacogenetic decision support tools in shared decision making","volume":"126","author":"Arandjelovic","year":"2019","journal-title":"J. Neural Transm."},{"issue":"8","key":"10.1016\/j.jpsychires.2019.04.017_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"65","author":"Association, A.D.","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2019.04.017_bib6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/gerona\/glp135","article-title":"Longitudinal association between depressive symptoms and disability burden among older persons","volume":"64","author":"Barry","year":"2009","journal-title":"J. Gerontol. Ser. A Biol. Med. Sci."},{"issue":"11","key":"10.1016\/j.jpsychires.2019.04.017_bib7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1525-1497.1998.00226.x","article-title":"Mortality, symptoms, and functional impairment in late-life depression","volume":"13","author":"Callahan","year":"1998","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib8","first-page":"A42","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states","volume":"3","author":"Colton","year":"2006","journal-title":"Prev. Chronic Dis."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/pcn.12110","article-title":"Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia","volume":"68","author":"Cort\u00e9s","year":"2014","journal-title":"Psychiatr. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.jpsychires.2019.04.017_bib10","doi-asserted-by":"crossref","first-page":"w770","DOI":"10.1377\/hlthaff.28.5.w770","article-title":"Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges","volume":"28","author":"Crystal","year":"2009","journal-title":"Health Aff."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1\u20133","key":"10.1016\/j.jpsychires.2019.04.017_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.schres.2007.10.003","article-title":"Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels","volume":"98","author":"de Leon","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review: drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"Domecq","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jpsychires.2019.04.017_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.acn.2008.06.004","article-title":"Utility of the RBANS in detecting cognitive impairment associated with Alzheimer's disease: sensitivity, specificity, and positive and negative predictive powers","volume":"23","author":"Duff","year":"2008","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.04.017_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0b013e3181ac9b0b","article-title":"Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies","volume":"29","author":"Fava","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2019.04.017_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1017\/S1461145712001241","article-title":"Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial","volume":"16","author":"Fleischhacker","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2019.04.017_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archgenpsychiatry.2011.2","article-title":"Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis","volume":"68","author":"Foley","year":"2011","journal-title":"Arch. Gen. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2710.2009.01084.x","article-title":"Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study","volume":"35","author":"Gebhardt","year":"2010","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.jpsychires.2019.04.017_bib19","article-title":"A clinical perspective of obesity, metabolic syndrome and cardiovascular disease","volume":"5","author":"Han","year":"2016","journal-title":"JRSM Cardiovasc. Dis."},{"issue":"12","key":"10.1016\/j.jpsychires.2019.04.017_bib20","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1038\/sj.npp.1301392","article-title":"Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients","volume":"32","author":"Haupt","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2019.04.017_bib21","series-title":"All of Us Research Program","author":"Health","year":"2018"},{"issue":"4","key":"10.1016\/j.jpsychires.2019.04.017_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"16","key":"10.1016\/j.jpsychires.2019.04.017_bib23","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2217\/pgs.13.207","article-title":"Genetics of antipsychotic-induced weight gain: update and current perspectives","volume":"14","author":"Kao","year":"2013","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/sim.1714","article-title":"Reconsidering the odds ratio as a measure of 2x2 association in a population","volume":"23","author":"Kraemer","year":"2004","journal-title":"Stat. Med."},{"issue":"11","key":"10.1016\/j.jpsychires.2019.04.017_bib25","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/sim.5734","article-title":"Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach","volume":"32","author":"Kraemer","year":"2013","journal-title":"Stat. Med."},{"issue":"2S","key":"10.1016\/j.jpsychires.2019.04.017_bib26","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1037\/0278-6133.27.2(Suppl.).S101","article-title":"How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches","volume":"27","author":"Kraemer","year":"2008","journal-title":"Health Psychol."},{"key":"10.1016\/j.jpsychires.2019.04.017_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jad.2015.12.067","article-title":"Mortality and life expectancy in persons with severe unipolar depression","volume":"193","author":"Laursen","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"10011","key":"10.1016\/j.jpsychires.2019.04.017_bib28","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/S0140-6736(15)00308-6","article-title":"Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Lenze","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jpsychires.2019.04.017_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications","volume":"17","author":"Lett","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2019.04.017_bib30","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1532-5415.1968.tb02103.x","article-title":"Cumulative illness rating scale","volume":"16","author":"Linn","year":"1968","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.jpsychires.2019.04.017_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"12","key":"10.1016\/j.jpsychires.2019.04.017_bib32","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.clinthera.2004.12.003","article-title":"Metabolic risk during antipsychotic treatment","volume":"26","author":"Newcomer","year":"2004","journal-title":"Clin. Ther."},{"issue":"8","key":"10.1016\/j.jpsychires.2019.04.017_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/070674370605100803","article-title":"The metabolic effects of antipsychotic medications","volume":"51","author":"Newcomer","year":"2006","journal-title":"Can. J. Psychiatr. Rev. Canad. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2019.04.017_bib34","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamapsychiatry.2018.1088","article-title":"Metabolic effects of antipsychotics in children (MEAC): a randomized clinical trial assessing treatment effects on adiposity and insulin sensitivity","volume":"75","author":"Nicol","year":"2018","journal-title":"JAMA Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.04.017_bib35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.beth.2017.02.001","article-title":"Advancing personalized medicine: application of a novel statistical method to identify treatment moderators in the coordinated anxiety learning and management study","volume":"48","author":"Niles","year":"2017","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jpsychires.2019.04.017_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brat.2017.01.001","article-title":"Applying a novel statistical method to advance the personalized treatment of anxiety disorders: a composite moderator of comparative drop-out from CBT and ACT","volume":"91","author":"Niles","year":"2017","journal-title":"Behav. Res. Ther."},{"issue":"10","key":"10.1016\/j.jpsychires.2019.04.017_bib37","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4088\/JCP.15m09863","article-title":"Antipsychotic treatment of adults in the United States","volume":"76","author":"Olfson","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2019.04.017_bib38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3389\/fnins.2017.00741","article-title":"The complex relationship between antipsychotic-induced weight gain and therapeutic benefits: a systematic review and implications for treatment","volume":"11","author":"Raben","year":"2017","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.04.017_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"6","key":"10.1016\/j.jpsychires.2019.04.017_bib40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ijo.2008.11","article-title":"Accuracy of body mass index in diagnosing obesity in the adult general population","volume":"32","author":"Romero-Corral","year":"2008","journal-title":"Int. J. Obes."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.04.017_bib41","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.jcp.0000130558.86125.5b","article-title":"A comparison of risperidone-induced weight gain across the age span","volume":"24","author":"Safer","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2019.04.017_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpsychires.2016.07.005","article-title":"Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder","volume":"81","author":"Smagula","year":"2016","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.04.017_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/YIC.0b013e3282f424d6","article-title":"Weight gain during olanzapine treatment for psychotic depression: effects of dose and age","volume":"23","author":"Smith","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.04.017_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/eip.12225","article-title":"Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia","volume":"11","author":"Strassnig","year":"2017","journal-title":"Early Interv. Psychiatry."},{"issue":"7","key":"10.1016\/j.jpsychires.2019.04.017_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/cap.2017.0147","article-title":"Predictors and moderators of antipsychotic-related weight gain in the treatment of early-onset schizophrenia spectrum disorders study","volume":"28","author":"Taylor","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2019.04.017_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00041444-200512000-00011","article-title":"Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs","volume":"15","author":"Theisen","year":"2005","journal-title":"Psychiatr. Genet."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.04.017_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/15622975.2015.1076173","article-title":"Association of orexin receptor polymorphisms with antipsychotic-induced weight gain","volume":"17","author":"Tiwari","year":"2016","journal-title":"World J. Biol. Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2019.04.017_bib48","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2013.1960","article-title":"A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials","volume":"70","author":"Wallace","year":"2013","journal-title":"JAMA Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.04.017_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.sapharm.2009.07.001","article-title":"Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey","volume":"9","author":"Wang","year":"2013","journal-title":"Res. Soc. Adm. Pharm."},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2019.04.017_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.psychres.2004.02.018","article-title":"Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation","volume":"133","author":"Wehmeier","year":"2005","journal-title":"Psychiatr. Res."},{"issue":"10","key":"10.1016\/j.jpsychires.2019.04.017_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/pds.1805","article-title":"Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder","volume":"18","author":"Wisniewski","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"9","key":"10.1016\/j.jpsychires.2019.04.017_bib52","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/pds.1781","article-title":"The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study","volume":"18","author":"Yood","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"10.1016\/j.jpsychires.2019.04.017_bib53","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","article-title":"Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.jpsychires.2019.04.017_bib54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(03)00018-9","article-title":"Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients","volume":"37","author":"Zimmermann","year":"2003","journal-title":"J. Psychiatr. Res."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618314006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618314006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:12:39Z","timestamp":1758366759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395618314006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":54,"alternative-id":["S0022395618314006"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.04.017","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Getting to precision psychopharmacology: Combining clinical and genetic information to predict fat gain from aripiprazole","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2019.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}